Rapid antigen self-test kit for simultaneous detection of SARS-CoV-2, Influenza A and B, and RSV from respiratory or blood specimens. Designed for point-of-care testing with simplified workflow enabling quick identification of multiple respiratory pathogens in clinical and home settings.
Manufactured by
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China
As pioneers of the world's first quantum dots POCT platform, we have led the industry for over 10 years since 2012, driven by relentless innovation and a commitment to excellence. We are dedicated to providing high-accuracy POCT product solutions, powered by our proprietary quantum dots platform, immunoassay technology, and comprehensive in vitro diagnostic expertise.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Reagen Inc.
United States · 2 relevant products
Soluções em Diagnóstico e Biotecnologia
Brazil · 1 relevant product
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 119 closest product alternatives
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked rapid self-test kit for simultaneous detection of SARS-CoV-2, Influenza A+B, and RSV with 92.9%+ sensitivity. Delivers point-of-care respiratory diagnostics using fluorescence immunoassay technology for clinical and home-based testing environments.
Reagen Inc. · United States
A rapid antigen detection test kit for the simultaneous detection of SARS-CoV-2, respiratory syncytial virus (RSV), adenovirus (ADV), influenza A, and influenza B antigens. The kit is designed for use in human diagnostic testing to identify active viral infections.
Soluções em Diagnóstico e Biotecnologia · Brazil
SARS-CoV-2 antigen rapid test kit for self-administration, enabling quick detection of active coronavirus infection at point-of-care. The test delivers results in minutes using molecular technology, suitable for clinical screening, workplace surveillance, and individual testing needs.
116 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products